PubMed

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.

Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW Jr.

Ann Intern Med. 2002 Oct 15;137(8):648-55.PMID: 12379064 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.

Colwell CW Jr, Berkowitz SD, Lieberman JR, Comp PC, Ginsberg JS, Paiement G, McElhattan J, Roth AW, Francis CW; EXULT B Study Group.

J Bone Joint Surg Am. 2005 Oct;87(10):2169-77.PMID: 16203879 [PubMed - indexed for MEDLINE]Related articles

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW Jr; EXULT A Study Group.

N Engl J Med. 2003 Oct 30;349(18):1703-12.PMID: 14585938 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.

J Thromb Haemost. 2003 Oct;1(10):2119-30.PMID: 14521593 [PubMed - indexed for MEDLINE]Related articles

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.

Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G; AstraZeneca Arthroplasty Study Group.

Arch Intern Med. 2001 Oct 8;161(18):2215-21.PMID: 11575978 [PubMed - indexed for MEDLINE]Related articlesFree article

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study.

Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Lassen MR, Mouret P, Rosencher N, Kälebo P, Panfilov S, Eskilson C, Andersson M, Freij A; EXPRESS Study Group.

J Thromb Haemost. 2003 Dec;1(12):2490-6.PMID: 14675083 [PubMed - indexed for MEDLINE]Related articles

Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.

Colwell C, Mouret P.

Semin Vasc Med. 2005 Aug;5(3):266-75. Review.PMID: 16123914 [PubMed - indexed for MEDLINE]Related articles

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS; THRIVE Treatment Study Investigators.

JAMA. 2005 Feb 9;293(6):681-9.PMID: 15701909 [PubMed - indexed for MEDLINE]Related articlesFree article

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.

Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Mouret P, Rosencher N, Eskilson C, Nylander I, Frison L, Ogren M; METHRO III Study Group.

Thromb Haemost. 2003 Feb;89(2):288-96.PMID: 12574809 [PubMed - indexed for MEDLINE]Related articles

Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery.

Evans HC, Perry CM, Faulds D.

Drugs. 2004;64(6):649-78. Review.PMID: 15018597 [PubMed - indexed for MEDLINE]Related articles

A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.

Eriksson BI, Arfwidsson AC, Frison L, Eriksson UG, Bylock A, Kälebo P, Fager G, Gustafsson D.

Thromb Haemost. 2002 Feb;87(2):231-7.PMID: 11858482 [PubMed - indexed for MEDLINE]Related articles

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.PMID: 15586625 [PubMed - indexed for MEDLINE]Related articles

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial.

Eriksson BI, Bergqvist D, Kälebo P, Dahl OE, Lindbratt S, Bylock A, Frison L, Eriksson UG, Welin L, Gustafsson D; Melagatran for Thrombin inhibition in Orthopaedic surgery.

Lancet. 2002 Nov 9;360(9344):1441-7.PMID: 12433510 [PubMed - indexed for MEDLINE]Related articles

Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.

Huisman MV, Bounameaux H.

Semin Vasc Med. 2005 Aug;5(3):276-84.PMID: 16123915 [PubMed - indexed for MEDLINE]Related articles

Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.

Fitzgerald RH Jr, Spiro TE, Trowbridge AA, Gardiner GA Jr, Whitsett TL, O'Connell MB, Ohar JA, Young TR; Enoxaparin Clinical Trial Group.

J Bone Joint Surg Am. 2001 Jun;83-A(6):900-6.PMID: 11407799 [PubMed - indexed for MEDLINE]Related articles

Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.

Schulman S, Wåhlander K, Lundström T, Clason SB, Eriksson H; THRIVE III Investigators.

N Engl J Med. 2003 Oct 30;349(18):1713-21.PMID: 14585939 [PubMed - indexed for MEDLINE]Related articlesFree article

[The oral direct thrombin inhibitor Ximelagatran Prophylaxis of venous thromboembolism in hip and knee replacement]

Mouret P.

Hamostaseologie. 2002 Aug;22(3):21-4. German. PMID: 12215757 [PubMed - indexed for MEDLINE]Related articles

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A; SPORTIF Executive Steering Committee for the SPORTIF V Investigators.

JAMA. 2005 Feb 9;293(6):690-8.PMID: 15701910 [PubMed - indexed for MEDLINE]Related articlesFree article

Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study.

Petersen P, Grind M, Adler J; SPORTIF II Investigators.

J Am Coll Cardiol. 2003 May 7;41(9):1445-51.PMID: 12742279 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Ximelagatran versus warfarin to prevent blood clots after knee replacement surgery.

[No authors listed]

Ann Intern Med. 2002 Oct 15;137(8):I38. No abstract available. PMID: 12379093 [PubMed - indexed for MEDLINE]Related articlesFree article